Ensysce Biosciences Receives Positive FDA Feedback on PF614 Manufacturing Approach

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/2/2026

1. DELL
2. MDT
3. PANW
4. SPY
5. AAPL
6. SPGI
7. USO
8. ENOV
9. GTLB
10. GPRO

Go back to Ensysce Biosciences Receives Positive FDA Feedback on PF614 Manufacturing Approach
(NASDAQ: ENSC) Delayed: 0.39 --0 (-0%)
Previous Close $0.39    52 Week High $ 
Open $0.39    52 Week Low $ 
Day High $0.39    P/E N/A 
Day Low $0.39    EPS $ 
Volume 871